GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper PublicationIntimation regarding 100 days Campaign - Saksham Niveshak
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals has informed the stock exchanges about newspaper advertisements published in Business Standard, Economic Times, and Maharashtra Times on 22–24 September 2025 as part of the IEPFA '100 Days Campaign – Saksham Niveshak', running from 28 July to 6 November 2025. The campaign reminds shareholders to update their KYC details and claim unclaimed or unpaid dividends for the last seven financial years before these are transferred to the Investor Education and Protection Fund (IEPF). The company has also issued reminder letters to such shareholders and shared the process and required documents (both for physical and demat holdings) via its Registrar, Kfin Technologies Limited. Additionally, the company has opened a special one-time window for re-lodgement of physical share transfer requests lodged before 1 April 2019 that were rejected or returned due to documentation issues, and is urging shareholders to convert physical shares into demat form.
This is a routine regulatory and shareholder-engagement filing with no direct impact on the company's financials or stock price. Shareholders who have unclaimed dividends or outdated KYC should act before 6 November 2025 to avoid their shares and dividends being transferred to the IEPF.